Jimmy Whitworth
Overview
Explore the profile of Jimmy Whitworth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
895
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Valayer S, Alexandre M, Prague M, Beavogui A, Doumbia S, Kieh M, et al.
Emerg Microbes Infect
. 2024 Nov;
14(1).
PMID: 39559990
rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo are WHO-prequalified vaccination regimens against Ebola virus disease (EVD). Challenges associated with measuring long-term clinical protection warrant the evaluation of immune response kinetics after vaccination. Data...
2.
Espindola O, Resende P, Guaraldo L, Amaral Calvet G, Fuller T, Penetra S, et al.
Mem Inst Oswaldo Cruz
. 2023 Oct;
118:e230069.
PMID: 37851721
Background: There is interest in lingering non-specific symptoms after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, referred to as Long coronavirus disease 2019 (Long COVID-19). It remains unknown whether...
3.
Handal N, Whitworth J, Lyngbakken M, Berdal J, Dalgard O, Jorgensen S
Infect Dis (Lond)
. 2023 Oct;
56(1):19-31.
PMID: 37795955
Objective: To compare mortality and length of hospital stay between patients with ESBL-producing bloodstream infections (BSIs) and patients with non-ESBL BSIs. We also aimed at describing risk factors for ESBL-producing...
4.
Penetra S, Santos H, Resende P, Soares Bastos L, da Silva M, Pina-Costa A, et al.
J Infect Dis
. 2023 Aug;
228(12):1680-1689.
PMID: 37571849
This was a household-based prospective cohort study conducted in Rio de Janeiro, in which people with laboratory-confirmed coronavirus disease 2019 (COVID-19) and their household contacts were followed from April 2020...
5.
Jones R, Tytheridge S, Smith S, Levine R, Hodges M, Ansumana R, et al.
Am J Trop Med Hyg
. 2023 Jun;
109(1):10-21.
PMID: 37277107
Sierra Leone is vulnerable to a wide range of vector-borne diseases transmitted by mosquitoes, tsetse flies, black flies, and other vectors. Malaria, lymphatic filariasis, and onchocerciasis have posed the greatest...
6.
Melo Espindola O, Fuller T, de Araujo M, Tort L, Guaraldo L, Calvet G, et al.
Sci Rep
. 2023 May;
13(1):7437.
PMID: 37156846
COVID-19 vaccines have dramatically reduced rates of severe infection requiring hospitalization. However, SARS-CoV-2 variants have reduced vaccine effectiveness at preventing any symptomatic infection. This real-world study analyzed binding and neutralizing...
7.
Calvet G, Ogrzewalska M, Tassinari W, Guaraldo L, Resende P, Fuller T, et al.
BMC Infect Dis
. 2023 May;
23(1):295.
PMID: 37147601
Background: While nasopharyngeal (NP) swabs are considered the gold standard for severe acute respiratory coronavirus 2 (SARS-CoV-2) real-time reverse transcriptase-polymerase chain reaction (RT-PCR) detection, several studies have shown that saliva...
8.
Brasil P, Damasceno L, Fuller T, Bastos L, Cruz O, Medeiros F, et al.
BMJ Open
. 2023 Jan;
12(12):e067212.
PMID: 36600372
Purpose: To better understand the household transmission of SARS-COV-2 in a low-resource community in Rio de Janeiro during the COVID-19 pandemic (2020-2022). Participants: This is an open prospective cohort study...
9.
Whitworth J
Trans R Soc Trop Med Hyg
. 2022 Sep;
116(9):761-762.
PMID: 36088279
No abstract available.
10.
Carvalho M, Soares Bastos L, Fuller T, Cruz O, Damasceno L, Calvet G, et al.
Lancet Reg Health Am
. 2022 Jun;
12:100283.
PMID: 35663637
Background: Incidence rates of SARS-CoV-2 infections in low-resource communities can inform vaccination strategies and non-pharmaceutical interventions (NPIs). Our objective was to estimate incidence over four epidemic waves in a slum...